Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction

(2011) Sergio Manzano-Fernández et al.   AMERICAN JOURNAL OF CARDIOLOGY

Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure

(2011) Domingo A. Pascual-Figal et al.   EUROPEAN JOURNAL OF HEART FAILURE

La monitorización de ST2 soluble proporciona una estratificación del riesgo adicional en pacientes ambulatorios con insuficiencia cardiaca descompensada

(2011) Antoni Bayes-Genis et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Statistical methods for assessment of added usefulness of new biomarkers

(2010) Michael J. Pencina et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum Soluble ST2

(2010) Robin A.P. Weir et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Aging Heart and Post-Infarction Left Ventricular Remodeling

(2010) Henry Shih et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2009) John J.V. McMurray et al.   CIRCULATION

Serum Levels of the Interleukin-1 Receptor Family Member ST2, Cardiac Structure and Function, and Long-Term Mortality in Patients With Acute Dyspnea

(2009) Ravi V. Shah et al.   Circulation-Heart Failure

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assay

(2009) Benjamin Dieplinger et al.   CLINICA CHIMICA ACTA

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

(2009) Hans Wedel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

(2009) John G.F. Cleland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

(2009) Domingo A. Pascual-Figal et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial Infarction

(2008) Marc S. Sabatine et al.   CIRCULATION

Increased Plasma Concentrations of Soluble ST2 are Predictive for 1-Year Mortality in Patients with Acute Destabilized Heart Failure

(2008) T. Mueller et al.   CLINICAL CHEMISTRY

Serial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart Failure

(2008) Saskia Boisot et al.   JOURNAL OF CARDIAC FAILURE

Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure

(2008) Shafiq U. Rehman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The IL-33/ST2 pathway: therapeutic target and novel biomarker

(2008) Rahul Kakkar et al.   NATURE REVIEWS DRUG DISCOVERY

Epidemiology and risk stratification in acute heart failure

(2007) Gregg C. Fonarow   AMERICAN HEART JOURNAL